Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001762963 | SCV001988991 | uncertain significance | not provided | 2017-05-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002449408 | SCV002682677 | uncertain significance | Cardiovascular phenotype | 2020-03-17 | criteria provided, single submitter | clinical testing | The p.D2938Y variant (also known as c.8812G>T), located in coding exon 36 of the TTN gene, results from a G to T substitution at nucleotide position 8812. The aspartic acid at codon 2938 is replaced by tyrosine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |